Pterostilbene
SupplementThe high negative divergence arises because the community reports cognitive effects and mood improvements [c1, c2] that have not yet been investigated in clinical human studies [s3, s2]. The medical score reflects the lack of validated human studies, while the community responds primarily to subjective self-reports.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Pterostilbene is a methylated stilbenoid with better bioavailability than resveratrol, but human research is limited to just two small RCTs (n=80 each) — cognitive and anti-aging effects exist only in animal and in vitro data so far. A clinically relevant LDL increase under monotherapy is the most important safety finding and should be taken seriously before starting supplementation. In the EU, pterostilbene sits in a legal grey zone without formal Novel Food authorization, making its sale as a supplement legally uncertain. Anyone taking it should monitor LDL regularly and be aware of anticoagulant interactions.
Description
Methylated stilbenoid from blueberries with higher bioavailability than resveratrol; initial RCT data on lipid profile and safety available, cognitive effects demonstrated only preclinically to date [s1,...
Pterostilbene is a naturally occurring polyphenol of the stilbenoid class, found primarily in blueberries, cranberries, and grapes [s1]. Structurally, it closely resembles the better-known resveratrol, but possesses two methoxy groups instead of hydroxy groups. This methylation markedly increases lipophilicity and thereby oral bioavailability compared to resveratrol — estimates indicate approximately 80% bioavailability versus considerably lower values for resveratrol [s4]. The plasma half-life of pterostilbene is approximately 105 minutes, whereas resveratrol is already half-degraded after about 14 minutes [s4]. Preclinical studies demonstrate antioxidant, anti-inflammatory, neuroprotective, hypolipidemic, and antidiabetic properties [s1, s2, s5, s6]. Human studies are limited, however: two published RCTs exist, examining primarily safety and metabolic parameters [s2, s3]. An important observation is that pterostilbene as monotherapy can significantly elevate LDL cholesterol levels, raising long-term cardiovascular risk concerns [s2]. Clinical evidence for cognitive effects, cancer prevention, and anti-aging actions in humans is lacking; corresponding claims are based on animal and in vitro data [s6, s7, s8]. In the biohacker community, pterostilbene is frequently combined with resveratrol to synergistically activate PPAR-alpha and SIRT1 signaling pathways [s4, s9].
Legal Status (DE)
In Germany and the EU, pterostilbene is regulatorily classified as a potential novel food ingredient. The European Commission evaluated an updated botanical status for pterostilbene extracts in the Novel Food Catalogue in 2026 [s12]. Products marketed as dietary supplements exist in a legal grey area; without formal EU novel food authorization, sale as a dietary supplement is legally uncertain. In the USA, pTeroPure® is classified as GRAS (Generally Recognized as Safe) [s11].
Mechanism of Action
Pterostilbene exerts its biological effects via multiple molecular targets [s1, s5, s6]: 1. **AMPK/SIRT1/PGC-1α axis**: Pterostilbene activates AMP-activated protein kinase (AMPK) and sirtuin-1 (SIRT1), thereby promoting mitochondrial biogenesis and energy homeostasis [s6, s7]. 2. **Nrf2 activation**: As a transcription factor for antioxidant defense mechanisms, Nrf2 is upregulated by pterostilbene, enhancing synthesis of glutathione and other endogenous antioxidants [s6]. 3. **PPAR-α activation**: In the heart, liver, and muscle, pterostilbene activates peroxisome proliferator-activated receptor alpha (PPAR-α), which influences lipid metabolism [s2, s5]. 4. **MAO-B inhibition**: Selective, competitive inhibition of monoamine oxidase B (MAO-B; IC50 ≈ 0.14 µM) has been demonstrated in vitro, which may explain dopaminergic effects [s9]. 5. **Neuroprotective mechanisms**: In animal models, pterostilbene reduces amyloid-related cognitive deficits via SIRT1-dependent neuroplasticity; cholinergic signaling pathways are also modulated through inhibition of acetylcholinesterase-mediated degradation [s7, s8]. 6. **Antioxidant activity**: Direct neutralization of reactive oxygen species (ROS) and protection of erythrocytes against oxidative hemolysis [s1].
Dosing
Metabolische Gesundheit / Lipidprofil
- Dose
- 50 mg twice daily (100 mg/day) or 125 mg twice daily (250 mg/day)
- Frequency
- 2× täglich
- Route
- oral
- Duration
- 6–8 Wochen
- Timing
- Morning and evening, with or without food
- With food
- optional
Kognitive Unterstützung (präklinisch begründet)
- Dose
- 50–100 mg daily
- Frequency
- 1× täglich
- Route
- oral
- Duration
- Fortlaufend, Langzeit-Sicherheitsdaten begrenzt
- Timing
- Morning
- With food
- optional
Kombination mit Resveratrol (Stack)
- Dose
- 50–100 mg pterostilbene + 150 mg resveratrol daily
- Frequency
- 1× täglich
- Route
- oral
- Duration
- Fortlaufend
- Timing
- Morning with a meal
- With food
- empfohlen
In human studies, doses up to 250 mg/day were used over 6–8 weeks without serious adverse events [s3]. Long-term safety data beyond this period are lacking. Doses above 250 mg/day are not supported by human data.
With pterostilbene monotherapy, LDL monitoring is warranted, as clinical data demonstrated a significant LDL increase with monotherapy [s2]. Combination with grape extract partially attenuated this effect in the study [s2].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| LDL-Cholesterin-Anstieg (Monotherapie) In the RCT by Riche et al. (2014), LDL increased by an average of 17.1 mg/dL under pterostilbene monotherapy (50 mg and 125 mg twice daily) (p=0.001). This effect was dose-independent and occurred in both dosing groups [s2]. | häufig | moderat |
| Kopfschmerzen und Schwindel Individual user reports in the community describe headaches and dizziness following intake; no statistically significant adverse events of this type have been documented in clinical trials [s3, c3]. | selten | leicht |
| Gastrointestinale Beschwerden (Übelkeit, Magenbeschwerden) In the safety study by Riche et al. (2013), no significant hepatic, renal, or metabolic adverse effects were observed; mild GI complaints were occasionally reported subjectively [s3]. | selten | leicht |
| Blutdrucksenkung (additiv zu Antihypertensiva) Pterostilbene has preclinically demonstrated blood pressure-lowering properties. In combination with antihypertensives, there is a theoretical risk of excessive blood pressure reduction [s5]. | theoretisch | moderat |
| Erhöhte Blutungsneigung (Kombination mit Antikoagulantien) Pterostilbene may possess antithrombotic properties and potentiate the effects of warfarin or other anticoagulants [s10]. | theoretisch | moderat |
Contraindications
Clinically documented LDL increase of >17 mg/dL with pterostilbene monotherapy may shift individuals with already elevated LDL into a higher risk category [s2].
Pterostilbene may potentiate the anticoagulant effect of anticoagulants and increase bleeding risk [s10].
Pterostilbene significantly inhibits UGT1A9 enzymes. Concomitant use of UGT1A9 substrates (e.g., certain NSAIDs, mycophenolate) may increase the AUC of these drugs by more than 50% [s13].
No safety data available for pregnancy and lactation. Use is not recommended due to absence of human data [s3].
Interactions
Synergistic
Pterostilbene preferentially activates PPAR-α, while resveratrol more potently activates SIRT1. The combination is intended to enable broader pathway coverage; additionally, grape extract (containing resveratrol precursors) attenuated the LDL increase observed under pterostilbene monotherapy in an RCT [s2, s4].
Theoretical synergy via the SIRT1/NAD+ axis; clinical evidence for the combination is currently lacking [c1].
Quercetin, kaempferol, and pterostilbene act synergistically in reducing reactive oxygen species (ROS) via the Nrf2-ARE signaling pathway. The combination can achieve a stronger antioxidant effect than the individual compounds alone.
Both pterostilbene and berberine activate AMPK and inhibit mTOR, which may lead to additive effects on glucose and lipid metabolism. The combination could be particularly beneficial in metabolic syndrome and NAFLD.
Pterostilbene and alpha-lipoic acid (ALA) are both Nrf2 activators and can jointly enhance antioxidant defense mechanisms. Both act on the Nrf2 signaling pathway via distinct mechanisms, enabling complementary effects.
Pterostilbene and fisetin both possess senolytic and antioxidant properties. A combination may enhance the clearance of senescent cells and the reduction of oxidative stress.
Pterostilbene and curcumin both activate the Nrf2 signaling pathway and possess anti-inflammatory properties. The combination may provide broader antioxidant and anti-inflammatory coverage.
Pterostilbene and CoQ10/ubiquinol are both fat-soluble antioxidants with mitochondrial activity. The combination may complement mitochondrial protection against oxidative stress and support energy production.
Caution
Enhanced anticoagulant effect possible; INR monitoring recommended [s10].
Additive antihypertensive effect possible; blood pressure monitoring recommended [s5].
Pterostilbene inhibits UGT1A9; AUC of affected drugs may increase by ≥50% at doses ≥100 mg/day [s13].
Pterostilbene may inhibit CYP enzymes and affect the metabolism of CYP2C9 substrates [s10].
Studies
Tier A — High Evidence
Outcome: Safety parameters: hepatic, renal, and metabolic markers
Effect Size: No significant adverse drug reactions on hepatic, renal, or glucose markers. 91.3% study completion rate.
Outcome: Metabolic parameters (lipids, blood pressure, blood glucose)
Effect Size: LDL increase +17.1 mg/dL with pterostilbene monotherapy (p=0.001); no significant LDL increase in the combination group with grape extract (p=0.47). No significant effects on blood pressure or blood glucose.
Tier B — Moderate Evidence
Outcome: Antioxidant activity and disease modification by pterostilbene
Effect Size: Summary of preclinical evidence for antioxidant, neuroprotective, and cardioprotective effects; no new human studies.
Outcome: Effects of pterostilbene on cardiovascular health
Effect Size: Positive preclinical effects on lipids and blood pressure documented; clinical validation limited.
Tier C — Low Evidence
Outcome: Cognitive effects in aging and Alzheimer's model animals
Effect Size: Cognitive improvements with low-dose pterostilbene in animal models.
Outcome: Anti-inflammatory and oncological effects
Effect Size: Pterostilbene inhibits inflammatory markers and exhibits antitumor activity in cell lines.
Outcome: Neuroprotective effects via SIRT1 in amyloid-beta-induced cognitive dysfunction
Effect Size: Pterostilbene 40 mg/kg i.g. significantly improved cognitive tests (Novel Object, Y-Maze, Morris Water Maze); SIRT1 inhibitor abolished the effect.
Community Evidence
Top reported benefits
- Subjective cognitive improvements (memory, concentration)
- Better memory performance compared to resveratrol
- Mild mood elevation and increased drive
- Combination with NR/NMN as a popular longevity stack
Top reported issues
- LDL elevation with regular use (documented multiple times)
- Headaches and dizziness upon initial doses
- Lack of noticeable effect in a subset of users
- Concerns regarding unclear novel food status in the EU
The LDL increase is actively discussed in the community and regarded as an important caveat against pterostilbene monotherapy [c1, c2]. Some users report persistent headaches and neurological symptoms following intake, potentially attributable to co-ingredients in combination products [c3]. The legal uncertainty in the EU is considered problematic by German users [c4].
Scientific Sources
- A Review of Pterostilbene Antioxidant Activity and Disease Modification
McCormack D, McFadden D (2013). Oxidative Medicine and Cellular LongevityBPMID:23691264DOI - Pterostilbene: Benefits, Side Effects, Drug Interactions
Nootropics Planet editorial team (2023). Nootropics PlanetCLink - pTeroPure Achieves GRAS Status
Supply Side SJ editorial team (2012). Supply Side SJBLink - Novel Foods: Major updates on botanical assessments – Pterostilbene
NutraIngredients editorial team (2026). NutraIngredientsBLink - Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes
Xu Y, Gao S, Jiang X, et al. (2020). Food and Chemical ToxicologyCPMID:31812603DOI - Pterostilbene on Metabolic Parameters: A Randomized, Double-Blind, and Placebo-Controlled Trial
Riche DM, Riche KD, Blackshear CT, et al. (2014). Evidence-Based Complementary and Alternative MedicineAPMID:25045355DOI - Analysis of Safety from a Human Clinical Trial with Pterostilbene
Riche DM, McEwen CL, Riche KD, et al. (2013). Journal of ToxicologyAPMID:23431291DOI - Pterostilbene vs. Resveratrol: comparative pharmacokinetics and longevity perspective
NOVOS Labs Science Team (2023). NOVOS Labs Blog / secondary reviewCLink - Effects of Pterostilbene on Cardiovascular Health and Disease
Zhang L, Zhou G, Song W, et al. (2024). Current Oncology (MDPI)BDOI - SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25–35-Induced Cognitive Deficits in Mice
Gu J, Yan X, Liang Y, et al. (2022). Frontiers in PharmacologyCPMID:35496289DOI - Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease
Chang J, Rimando A, Pallas M, et al. (2012). Neurobiology of AgingCPMID:21925775DOI - Pterostilbene in the treatment of inflammatory and oncological diseases
Kostelecka K, Komar O, Michalczyk J, et al. (2023). Frontiers in PharmacologyBDOI - Pterostilbene + Resveratrol Reddit Discussion: MAO-B inhibition and user experiences
Reddit r/Nootropics community (2021). Reddit r/NootropicsDLink
Community Sources
Storage
Unopened
Store cool, dry, and protected from direct light; room temperature (15–25 °C).
Opened
Keep container tightly closed; avoid moisture and heat.
Notes
Pterostilbene is light-sensitive; dark packaging preferred. No special refrigeration requirements, but avoid temperatures above 30 °C.